Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
285 hedge funds and large institutions have $3.04B invested in Amedisys in 2024 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 78 increasing their positions, 101 reducing their positions, and 45 closing their positions.
6% more capital invested
Capital invested by funds: $2.85B → $3.04B (+$184M)
1.07% more ownership
Funds ownership: 94.99% → 96.06% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 13 → 13 (0)
2% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 45
1% less funds holding
Funds holding: 288 → 285 (-3)
23% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 101
84% less call options, than puts
Call options by funds: $15.6M | Put options by funds: $97.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
+$52.6M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$48.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$47.1M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$42.4M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$29.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$98.5M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$41M |
| 3 |
Millennium Management
New York
|
-$30.6M |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$24.3M |
| 5 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
-$24.1M |
AMED Hedge Fund Activity: Q3 2024 in Review
285 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2024, worth a combined $3.04B — up 6.5% from $2.85B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of AMED and 44 opened new positions — a net loss of 1 holder — while 101 trimmed existing stakes and 78 added.
The largest buyer was Kite Lake Capital Management (UK), opening a new position worth an estimated $52.6M. The largest seller was Goldman Sachs, cutting an estimated $98.5M.
- 285 institutional investors held Amedisys (AMED) as of Q3 2024, down from 288 in Q2 2024.
- Funds reported $3.04B of Amedisys stock for Q3 2024, up 6.5% quarter-over-quarter.
- 44 funds opened new Amedisys positions in Q3 2024 and 45 closed out, a net change of -1 holder.
- The largest Amedisys buyer in Q3 2024 was Kite Lake Capital Management (UK), an estimated $52.6M added.
- The largest Amedisys seller in Q3 2024 was Goldman Sachs, an estimated $98.5M sold.
Based on aggregated 13F filings for Q3 2024.